Addex Therapeutics Ltd (FRA:APE)

Germany flag Germany · Delayed Price · Currency is EUR
0.0605
+0.0235 (63.51%)
At close: Jul 3, 2025
-95.58%
Market Cap 6.23M
Revenue (ttm) 257.68K
Net Income (ttm) 9.07M
Shares Out n/a
EPS (ttm) 0.09
PE Ratio 0.69
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 48
Open 0.0605
Previous Close 0.0370
Day's Range 0.0605 - 0.0605
52-Week Range 0.0370 - 1.3700
Beta n/a
RSI 24.23
Earnings Date Sep 1, 2025

About Addex Therapeutics

Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes. Its lead programs include Dipraglurant, which is in phase 1 clinical trial for the treatment of post-stroke/TBI recovery, as well as to treat Parkinson’s disease levodopa-induced dyskinesia. The company also develops ADX71149, a novel orally active metabotropic glutamate receptor subtype 2 positive allosteric modulator (mG... [Read more]

Industry Pharmaceutical Preparations
Founded 2002
Employees 2
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol APE
Full Company Profile

Financial Performance

Financial numbers in CHF Financial Statements

News

There is no news available yet.